1. Second course of systemic dexamethasone: efficacy and respiratory function changes
- Author
-
Theodore Dassios, Anne Greenough, and Ourania Kaltsogianni
- Subjects
Male ,business.industry ,Respiration ,Infant, Newborn ,Infant ,Obstetrics and Gynecology ,Respiration, Artificial ,Dexamethasone ,03 medical and health sciences ,0302 clinical medicine ,030225 pediatrics ,Anesthesia ,Pediatrics, Perinatology and Child Health ,Airway Extubation ,Humans ,Medicine ,Respiratory function ,030212 general & internal medicine ,business ,Ventilator Weaning ,Infant, Premature ,Retrospective Studies ,medicine.drug - Abstract
There is a paucity of data concerning the efficacy of a second course of systemic postnatal corticosteroids resulting in a successful extubation of prematurely-born, ventilated infants and its effect on their respiratory function.To determine the efficacy of a second course of systemic dexamethasone in successful extubation of prematurely-born infants and to describe the respiratory function changes that occur following the administration of the second course.Retrospective cohort study of ventilated infants less than 30 weeks of gestation who received a nine-day second course of intravenous dexamethasone in a tertiary neonatal unit. Extubation was deemed successful if the infants were not re-intubated within 72 h of the extubation attempt. We calculated the ventilation perfusion ratio (VFifteen (10 male) infants with a median (IQR) gestational age (GA) of 25.7 (24.7-26.6) weeks and a birth weight of 0.79 (0.67-0.93) kg were studied at a postnatal age of 60 (48-73) days. Fourteen of fifteen infants (93%) were successfully extubated. The VA second course of systemic dexamethasone appears efficient in weaning premature infants off invasive ventilation and is associated with a significant improvement in oxygenation.
- Published
- 2020
- Full Text
- View/download PDF